Logo image of FGEN

FIBROGEN INC (FGEN) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:FGEN - US31572Q8814 - Common Stock

9.71 USD
+0.69 (+7.65%)
Last: 1/7/2026, 8:00:00 PM
9.75 USD
+0.04 (+0.41%)
After Hours: 1/7/2026, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
FGEN revenue by date.FGEN revenue by date.
140.7M
-40.20%
46.803M
-66.74%
29.621M
-36.71%
6.885M
-76.76%
6.242M
-9.34%
6.242M6.324M
1.31%
286.62M
4,432.26%
294.78M
2.85%
EBITDA
YoY % growth
FGEN ebitda by date.FGEN ebitda by date.
-290.4M
-6.11%
-300.185M
-3.37%
-128.27M
57.27%
-46.308M
63.90%
-47.226M
-1.98%
-51.918M
-9.94%
-57.528M
-10.81%
N/AN/A
EBIT
YoY % growth
FGEN ebit by date.FGEN ebit by date.
-301M
-4.33%
-310.115M
-3.03%
-130.962M
57.77%
-46.614M
64.41%
-48.603M
-4.27%
-58.599M
-20.57%
-57.528M
1.83%
31.62M
154.96%
41.82M
32.26%
Operating Margin
FGEN operating margin by date.FGEN operating margin by date.
-213.93%-662.60%-442.13%-677.04%-778.64%-938.79%-909.68%11.03%14.19%
EPS
YoY % growth
FGEN eps by date.FGEN eps by date.
-78.50-70.00
10.83%
-12.00
82.86%
-4.70
60.86%
-12.19
-159.50%
-10.87
10.84%
-7.05
35.15%
0.26
103.62%
0.31
20.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth
-3.96
-188.06%
-4.38
-450.06%
-4.34
-130.59%
-4.53
-39.35%
-4.49
-13.26%
-4.17
4.66%
-4.60
-6.12%
-5.02
-10.81%
-4.97
-10.68%
-4.92
-17.85%
-4.87
-5.76%
-4.81
4.07%
-4.77
3.90%
Revenue
Q2Q % growth
1.703M
-96.62%
1.54M
-43.78%
1.54M
14.24%
1.54M
43.12%
1.54M
-9.57%
1.54M1.54M1.54M1.54M1.54M1.54M1.54M1.54M
EBITDA
Q2Q % growth
-13.26M
84.94%
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-14.28M
84.27%
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-3.25
23.53%
-4.090.8420.44%
Q2 2025
Q2Q % growth
-1.88
53.00%
-2.350.4720.04%
Q1 2025
Q2Q % growth
1.25
115.15%
0.510.74145.10%
Q4 2024
Q2Q % growth
4.50
131.58%
-3.578.07226.05%
Q3 2024
Q2Q % growth
-4.25
67.31%
-7.783.5345.36%
Q2 2024
Q2Q % growth
-4.00
82.22%
-8.164.1650.98%
Q1 2024
Q2Q % growth
-8.25
59.26%
-10.712.4622.97%
Q4 2023
Q2Q % growth
-14.25
18.57%
-10.84-3.41-31.49%
Q3 2023
Q2Q % growth
-13.00
46.94%
-17.344.3425.03%
Q2 2023
Q2Q % growth
-22.50
-15.38%
-17.93-4.57-25.45%
Q1 2023
Q2Q % growth
-20.25
-19.12%
-19.21-1.04-5.41%
Q4 2022
Q2Q % growth
-17.50
51.72%
-23.936.4326.86%
Q3 2022
Q2Q % growth
-24.50
-281.48%
-20.66-3.84-18.62%
Q2 2022
Q2Q % growth
-19.50
46.21%
-23.894.3918.36%
Q1 2022
Q2Q % growth
-17.00
12.82%
-21.214.2119.84%
Q4 2021
Q2Q % growth
-36.25
-126.56%
-16.90-19.35-114.46%
Q3 2021
Q2Q % growth
13.50
54.29%
-0.1513.658,923.53%
Q2 2021
Q2Q % growth
-36.25
-52.63%
-12.29-23.96-194.93%
Q1 2021
Q2Q % growth
-19.50
12.36%
-22.112.6111.80%
Q4 2020
Q2Q % growth
-16.00 -6.01-9.99-166.17%
Q3 2020
Q2Q % growth
8.75 -20.4029.15142.89%
Q2 2020
Q2Q % growth
-23.75 -16.33-7.42-45.48%
Q1 2020
Q2Q % growth
-22.25 -9.91-12.34-124.59%
FGEN Yearly EPS VS EstimatesFGEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -20 -40 -60 -80
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
1.076M
-97.68%
1.673M-597K-35.68%
Q2 2025
Q2Q % growth
1.348M
-97.34%
2.683M-1.335M-49.76%
Q1 2025
Q2Q % growth
2.739M
-95.10%
1.54M1.199M77.86%
Q4 2024
Q2Q % growth
50.408M
85.75%
25.408M25M98.39%
Q3 2024
Q2Q % growth
46.333M
15.45%
35.458M10.875M30.67%
Q2 2024
Q2Q % growth
50.641M
14.26%
35.354M15.287M43.24%
Q1 2024
Q2Q % growth
55.902M
54.59%
37.4M18.502M49.47%
Q4 2023
Q2Q % growth
27.137M
-21.11%
39.679M-12.542M-31.61%
Q3 2023
Q2Q % growth
40.134M
155.63%
37.577M2.557M6.80%
Q2 2023
Q2Q % growth
44.319M
48.72%
35.43M8.889M25.09%
Q1 2023
Q2Q % growth
36.161M
-40.52%
32.474M3.687M11.35%
Q4 2022
Q2Q % growth
34.4M
108.48%
24.52M9.88M40.29%
Q3 2022
Q2Q % growth
15.7M
-89.94%
32.221M-16.521M-51.27%
Q2 2022
Q2Q % growth
29.8M
22.13%
35.079M-5.279M-15.05%
Q1 2022
Q2Q % growth
60.8M
58.33%
29.33M31.47M107.30%
Q4 2021
Q2Q % growth
16.5M
-74.62%
48.606M-32.106M-66.05%
Q3 2021
Q2Q % growth
156M
254.55%
146.33M9.67M6.61%
Q2 2021
Q2Q % growth
24.4M
-43.12%
70.448M-46.048M-65.36%
Q1 2021
Q2Q % growth
38.4M
57.38%
42.623M-4.223M-9.91%
Q4 2020
Q2Q % growth
65M 102.83M-37.83M-36.79%
Q3 2020
Q2Q % growth
44M 65.461M-21.461M-32.78%
Q2 2020
Q2Q % growth
42.9M 34.476M8.424M24.43%
Q1 2020
Q2Q % growth
24.4M 74.031M-49.631M-67.04%
FGEN Yearly Revenue VS EstimatesFGEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS10.69% 6.83% 17.62% 17.62%
Revenue0% 0.29% 0.75% 0.75%